| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099656 | Journal of Crohn's and Colitis | 2013 | 6 Pages |
Abstract
This study shows that adalimumab is an effective treatment in patients with UC. If used as a second anti-TNF, previous achievement of remission with the first anti-TNF predicts response, and failure to achieve response at week 12 predicts colectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Orlando GarcÃa-Bosch, Javier P. Gisbert, Ãlex Cañas-Ventura, Olga Merino, José L. Cabriada, Valle GarcÃa-Sánchez, Ana Gutiérrez, Pilar Nos, Mireia Peñalva, Joaquin Hinojosa, Esther GarcÃa-Planella, Fernando Muñoz, Xavier Calvet, Julián Panés,